Market Access & Post Approval | Geistek Pharmaceuticals
Geistek
Book a Call
From approval to a successful commercial launch

Market access and post-approval support, so regulatory success becomes commercial success

Support from approval to market — pricing, reimbursement, HTA, and payer engagement, so your regulatory work actually translates into patients accessing your medicine.

Pricing & Reimbursement HTA Dossiers Payer Engagement Launch Readiness
Approval-to-Launch Bridge Interactive overview

👆 Click each stage — from regulatory to commercial

Regulatory Market
Regulatory side
Approval secured
The regulatory dossier is approved — but approval alone doesn't guarantee patients can access the medicine yet.

Illustrative overview of a typical approval-to-launch journey

A CRO You Can Trust

Direct, transparent communication at every stage — no middlemen, no fine print.

Budget Adapted to Your Launch

Flexible plans based on your product's market and launch timeline.

Continuity from Approval to Launch

No handoffs between regulatory approval and market access planning.

Real Experience on Both Sides

Direct knowledge of both regulatory requirements and payer expectations.

How We Work

From approval to a launch that actually reaches patients

01

Post-Approval Readiness Assessment

We review your approval status and where market access planning should begin.

02

Pricing & Reimbursement Strategy

We define the pricing and reimbursement approach for your target markets.

03

HTA Dossier & Payer Engagement

We prepare your HTA submission and support engagement with payers.

04

Launch Readiness & Commitments

We support your launch and stay accountable for post-approval commitments.

What's Included

Support that continues after the regulatory dossier is closed

Market Access Strategy

A single strategy connecting your regulatory approval to a realistic path to market.

02

Pricing & Reimbursement Support

Pricing and reimbursement strategy tailored to your target markets and product profile.

03

HTA Dossier Preparation

Health Technology Assessment dossiers prepared ahead of approval, not scrambled together after.

04

Payer Engagement

Structured engagement with payers to support access decisions in your target markets.

05

Launch Readiness Planning

A readiness plan connecting regulatory approval to a commercially viable launch.

06

Post-Approval Commitments

Ongoing management of post-approval studies and commitments (such as PASS/PAES) after launch.

Why Choose Geistek

Approval is not the finish line, it's the halfway point

Approval doesn't guarantee patients can actually access the medicine

Without a pricing and reimbursement strategy, an approved medicine can sit unavailable to the patients who need it.

We plan market access alongside your regulatory strategy, not after

Market access planning starts before approval lands, not once it's already a scramble.

HTA and payer requirements catch teams off guard after approval

Teams that focused only on regulatory approval often discover HTA requirements too late to plan properly.

We prepare your HTA dossier before approval lands

Health Technology Assessment requirements are anticipated, not discovered after the fact.

Post-approval commitments get deprioritized once the team moves on

PASS/PAES commitments can slip once attention shifts to the next program.

We stay accountable for post-approval commitments after launch

Someone stays responsible for your post-approval obligations, even after launch is underway.

Our Model

One team, from the regulatory dossier to the commercial launch

01

Real Experience on Both Sides

Direct knowledge of both regulatory requirements and payer expectations, not just one side of the process.

02

Continuity from Approval to Launch

No handoffs between the regulatory team and the market access team — one continuous thread.

03

Budget Adapted to Your Launch

Flexible plans based on your target markets and launch timeline.

Let's Start the Conversation

Tell us where your launch plan stands today

We'll review your approval timeline and tell you, with no obligation, what market access work should already be underway.

Prefer to talk directly? Book 20 minutes with our team, no form needed.
Book a Call →

Request a Consultation

We typically respond within 24-48 business hours.

⚠ Form not connected yet. Send me the WPForms ID for this landing page and I'll swap this note for .
Response within 24-48h No obligation Confidential by default
© Geistek Pharmaceuticals — Market Access & Post Approval